The Guardian: A woman in Oxford has become the first British volunteer to be injected with an experimental Ebola vaccine, which, if it works, will be fast-tracked for use in west Africa.
BBC: The first healthy volunteer has received an experimental Ebola vaccine in Oxford.
Press release: Oxford University’s Jenner Institute is to start clinical safety tests of a candidate Ebola vaccine, aimed at preventing the disease that has killed more than 1,200 people in the current outbreak in West Africa.
Helen McShane, BSc MBBS PhD London, Faculty of Clinical Medicine, has been voted onto Oxford University Council. From September, she will represent two Divisions: Medical Sciences (MedSci) and Mathematical, Physical and Life Sciences (MPLS). This is a prestigious post which will put one of ...
Press release: A novel malaria vaccine developed at Oxford University has shown promising results in the first clinical trial to test whether it can protect people against the mosquito-borne disease.
BBC Radio 4: HIV has been one of modern medicine's most implacable foes. Thirty one years since AIDS was first observed in the west with 30m deaths worldwide since, it has been tamed but not beaten.
CBS: An experimental malaria vaccine once thought promising is turning out to be a disappointment, with a new study showing it is only about 30 percent effective at protecting infants from the killer disease.
BBC: Medical correspondent Fergus Walsh explains how British scientists have used a new technique to develop a synthetic virus which heralds a major development in vaccines.
BBC: British scientists have developed a new, safer, method of creating vaccines using a particle accelerator, according to research published in the PLOS Pathogens journal.
A trial of a GSK/NIH candidate Ebola vaccine at Oxford University suggests the vaccine has an acceptable safety profile and is able to generate an immune response.
If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.